NephroLife Of India Draws $25 Million For Kidney Care From DaVita Of U.S.
This article was originally published in PharmAsia News
Executive Summary
India’s NephroLife Care sold a $25 million stake to DaVita of the U.S., which bought the interest to gain access to the Indian market.